Erb Takes Root As Sunshine Heart CEO
This article was originally published in Clinica
Executive Summary
Heart failure device developer Sunshine Heart Inc. has appointed John Erb CEO, effective March 2. Erb had been filling in as interim CEO after the departure of former chief David Rosa in December. Rosa left amid the company’s struggles with the US pivotal trial for its C-Pulse system. Erb, who has more than 40 years of experience in medical device leadership and financial posts, has served as the director of Sunshine Heart since September 2012 and was named chairman in October 2012. He is a founder of NuAx Inc. – formerly Cardia Access Inc. – and from 2001 through 2006 he served as CEO of CHF Solutions Inc., which was acquired by Gambro Inc.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.